Stanford Medicine
Subscribe to Stanford Medcast, where we bring insights from the world’s leading physicians and scientists on hot topics in medicine, healthcare, and education. Available on Medcast.stanford.edu and wherever you listen to podcasts.
Anti-PD-L1 Therapy in Urothelial Carcinoma: What Does the Clinical Trial Data Suggest on the Use of FDA Approved Atezolizumab?
By
Stanford Medicine
FEATURING
Sandy Srinivas
By
Stanford Medicine
FEATURING
Sandy Srinivas
Comments 0
Login to view comments.
Click here to Login
